Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.66%
#2 Venom Venom +22.52%
#3 aelf aelf +12.97%
#4 TRIA TRIA +8.74%
#5 Decred Decred +7.98%
#6 Status Status +7.87%
#7 DexNet DexNet +7.56%
#8 MarsCoin MarsCoin +7.36%
#9 Pons Pons +7.15%
#10 Wibx Wibx +5.97%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Vectorite Biomedical Inc. Vectorite Biomedical Inc.

Vectorite Biomedical Inc.

4170
Rang in Aktien #30357
Vectorite Biomedical Inc., established in 1993 and based in New Taipei City,... Vectorite Biomedical Inc., established in 1993 and based in New Taipei City, Taiwan, is a biotechnology firm dedicated to research and development activities globally, including a strong presence in its home country. The company's operations encompass the manufacturing of specialized cell preparation products, in addition to providing full-spectrum services for the collection, processing, and secure storage management of immune cells. These advanced cellular preparations are vital for applications in the medical fields of infectious diseases, inflammatory conditions, and various oncological and tumor-related illnesses.
Aktienkurs
$0.392718
Zuletzt synchronisiert: 2026-08-18
Marktkapitalisierung
$17.19M
Veränderung (1 Tag)
0.41%
Veränderung (1 Jahr)
-8.65%
Land
TW
Handel Vectorite Biomedical Inc. (4170)

Kategorie

Healthcare
P/S-Verhältnis für Vectorite Biomedical Inc. (4170)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Vectorite Biomedical Inc. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Vectorite Biomedical Inc. von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE